Back
Invesco S&P 500® Enhanced Value ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
39
SPVU
Invesco S&P 500® Enhanced Value ETF
Last Price:
47.71
Seasonality Move:
2.35%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Sell
39
Invesco S&P 500® Enhanced Value ETF (SPVU)
is a Sell
Is Invesco S&P 500® Enhanced Value ETF a Buy, Sell or Hold?
- The current Invesco S&P 500® Enhanced Value ETF [SPVU] share price is $47.70. The Score for SPVU is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- SPVU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPVU Stock Price Chart
What is Invesco S&P 500® Enhanced Value ETF's stock price today?
-
The Invesco S&P 500® Enhanced Value ETF share price today is $47.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPVU is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
SPVU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 47.14 | Sell |
Chaikin Money Flow: | 483 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.44 - 48.58) | Sell |
Bollinger Bands (100): | (46.18 - 48.94) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 45.77 | Sell |
Chaikin Money Flow: | 722527 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.99 - 42.29) | Sell |
Bollinger Bands (100): | (41.03 - 48.83) | Sell |
SPVU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.46 | Buy |
20-day SMA: | 47.79 | Sell |
50-day SMA: | 48.1 | Sell |
200-day SMA: | 44.58 | Buy |
8-day EMA: | 47.62 | Buy |
20-day EMA: | 47.81 | Sell |
50-day EMA: | 47.9 | Sell |
200-day EMA: | 45.52 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.38 | Sell |
20-day SMA: | 40.41 | Sell |
50-day SMA: | 41.94 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.76 | Sell |
20-day EMA: | 40.54 | Sell |
50-day EMA: | 42.03 | Sell |
200-day EMA: | 43.46 | Sell |
Invesco S&P 500® Enhanced Value ETF Earnings Growth & SPVU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Invesco S&P 500® Enhanced Value ETF Technical Analysis
Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |